Profile

Logo	Name	Type	Year of Establishment	Industry Tag
	Element Biosciences	Startup	2017	Synthetic Biology
Hi we’re Element Biosciences! Element Biosciences is a life science company that develops advanced DNA sequencing and multi-omics technologies to support synthetic biology research. Its AVITI™ system, powered by proprietary Avidite Base Chemistry (ABC), offers high-quality, cost-effective genomic analysis, facilitating applications such as gene circuit design and engineered cell profiling
	Abcam	Industry Player	1998
Hi we’re Abcam! Abcam is a global life sciences company that provides high-quality biological reagents and tools essential for synthetic biology research. It supplies antibodies, proteins, and assay kits widely used in genetic engineering, cell signaling, and synthetic circuit development.
	ND Capital	Investor	2002	Medical
Hi we’re ND Capital! ND Capital, formerly known as NanoDimension, is a venture capital firm investing in disruptive technologies across the life, physical, and data sciences sectors . In synthetic biology, it has backed companies like Constructive Bio, which engineers custom genomes and novel biomolecules for applications in therapeutics and sustainable materials
	Fine Structure Ventures	Investor	2020
Hi we’re Fine Structure Ventures! Fine Structure Ventures is a Cambridge-based venture capital firm specializing in early-stage investments in deep scientific innovation, including synthetic biology. Their portfolio features companies like Constructive Bio, which engineers custom genomes for novel biomolecules, and Debut Biotech, utilizing cell-free biomanufacturing to produce sustainable ingredients for various industries.
	Paladin Capital	Investor	2001
Hi we’re Paladin Capital! Paladin Capital Group is a multi-stage investment firm backing synthetic biology innovators like Constructive Bio, which engineers custom genomes, and Twist Bioscience, a pioneer in high-throughput DNA synthesis. The firm is also expanding into digital biology, blending AI and biotech to accelerate next-generation therapeutics
	OMX Ventures	Investor	2020
Hi we’re OMX Ventures! OMX Ventures is an early-stage venture capital firm investing at the intersection of biology, big data, and AI, with a focus on synthetic biology platforms. Its portfolio includes Constructive Bio, advancing whole-genome writing, and Inscripta, streamlining CRISPR-based genome engineering
	Ahren Innovation Capital	Investor	2017
Hi we’re Ahren Innovation Capital! Ahren Innovation Capital is a deep tech-focused investment firm backing breakthrough synthetic biology startups. It has funded companies like Constructive Bio, which engineers custom genomes, and Rubedo Life Sciences, targeting age-related diseases.
	SevenVentures	Investor	2011	Food
Hi we’re SevenVentures! SevenVentures, the investment arm of ProSiebenSat.1 Media SE, specializes in media-for-equity investments to accelerate growth for B2C companies. While not directly focused on synthetic biology, it has invested in foodtech companies like Planted Foods GmbH, which develops plant-based meat alternatives .